Cell-mediated immunity in neurologic disease.
D002493:Central Nervous System Diseases / Q000276:immunology; D003711:Demyelinating Diseases / Q000276:immunology; D003882:Dermatomyositis / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D007694:Killer Cells, Natural / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D008215:Lymphocytes, Null / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D008934:Mitogens / Q000494:pharmacology; D009103:Multiple Sclerosis / Q000276:immunology / Q000473:pathology; D009157:Myasthenia Gravis / Q000276:immunology; D009220:Myositis / Q000276:immunology; D009422:Nervous System Diseases / Q000134:cerebrospinal fluid / Q000276:immunology*; D010523:Peripheral Nervous System Diseases / Q000276:immunology; D010641:Phenotype; D013601:T-Lymphocytes / Q000276:immunology; D014777:Virus Diseases / Q000276:immunology
D008934:Mitogens